ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

Advanced HR-Positive Breast Cancer: Oral SERDs in Focus

Автор: Medscape

Загружено: 2025-06-30

Просмотров: 237

Описание: Join us for a live discussion on oral selective estrogen receptor degraders (SERDs) in advanced breast cancer (BC), designed to encourage the exchange of ideas between leaders in the field and attendees.

Moderator: Paolo Tarantino, MD, PhD
Faculty: Eva Ciruelos, MD, PhD
Faculty: Valentina Guarneri, MD, PhD

This event is EBAC accredited. Click the link to view the Accreditation and Disclosure details before participating:
https://www.medscape.org/viewarticle/...

Supported by an independent educational grant from AstraZeneca

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Advanced HR-Positive Breast Cancer: Oral SERDs in Focus

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

How treatment for early-stage breast cancer has changed

How treatment for early-stage breast cancer has changed

Estrogen Receptors &  HER2/neu Receptors in Breast Cancer (a TUTORIAL from Oster Oncology)

Estrogen Receptors & HER2/neu Receptors in Breast Cancer (a TUTORIAL from Oster Oncology)

What Causes Tension Heodoc

What Causes Tension Heodoc

T2D Myth Busters: AID Standards - What Is Available?

T2D Myth Busters: AID Standards - What Is Available?

ASCO 2025 Recap: Melanoma Highlights on TILs, Toxicity, and Diet-Driven Outcomes

ASCO 2025 Recap: Melanoma Highlights on TILs, Toxicity, and Diet-Driven Outcomes

Living with Alpha gal Syndrome

Living with Alpha gal Syndrome

⚡️НОВОСТИ | ДРОН ВЛЕТЕЛ НА 18-Й ЭТАЖ | СОТНИ ТЫСЯЧ БЕЗ ТЕПЛА | ЗАЯВЛЕНИЕ ПУТИНА | СТРЕЛЬБА В МОСКВЕ

⚡️НОВОСТИ | ДРОН ВЛЕТЕЛ НА 18-Й ЭТАЖ | СОТНИ ТЫСЯЧ БЕЗ ТЕПЛА | ЗАЯВЛЕНИЕ ПУТИНА | СТРЕЛЬБА В МОСКВЕ

Oral SERDs Explained: A New Option for Breast Cancer Patients

Oral SERDs Explained: A New Option for Breast Cancer Patients

RAS-Targeted Strategies in Pancreatic Cancer Progress and Future Directions

RAS-Targeted Strategies in Pancreatic Cancer Progress and Future Directions

ADA 2025: Clinical Trial Data on Incretin Therapies

ADA 2025: Clinical Trial Data on Incretin Therapies

AI Transforms Health Care | Artificial Intelligence: The Future of Medicine & Health Care Is Here

AI Transforms Health Care | Artificial Intelligence: The Future of Medicine & Health Care Is Here

Talleres pacientes SOLTI | Novedades congresos científicos cáncer de mama luminal

Talleres pacientes SOLTI | Novedades congresos científicos cáncer de mama luminal

Medicare at 60: Care, Cost, Control

Medicare at 60: Care, Cost, Control

The emerging role of SERD's in HR+ breast cancer

The emerging role of SERD's in HR+ breast cancer

What's the Best Diet for Hormone Receptor-Positive Breast Cancer? The Ultimate Guide for HR+

What's the Best Diet for Hormone Receptor-Positive Breast Cancer? The Ultimate Guide for HR+

The Pandemic Literally Aged Our Brains | Impact Factor | Medscape

The Pandemic Literally Aged Our Brains | Impact Factor | Medscape

What to Know About Infusion Therapies in Parkinson’s Disease

What to Know About Infusion Therapies in Parkinson’s Disease

Pneumococcal Vaccine Recommendations | TRC Healthcare Clinical Capsules Podcast

Pneumococcal Vaccine Recommendations | TRC Healthcare Clinical Capsules Podcast

lidERA trial: giredestrant improves invasive disease-free survival in ER+/HER2- early breast cancer

lidERA trial: giredestrant improves invasive disease-free survival in ER+/HER2- early breast cancer

Мой опыт таргетной терапии — рибоциклиб/кискали при метастатическом раке молочной железы

Мой опыт таргетной терапии — рибоциклиб/кискали при метастатическом раке молочной железы

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]